Nexalin goes public with $9.6M offering

Mental health neurostimulation company Nexalin is going public with a $9.6 million initial public offering.

Nexalin is offering 2,315,000 shares of common stock at $4.15 per share. Nexalin will trade under the ticker name "NXL," according to the Sept. 15 company news release.

Trading for Nexalin on the Nasdaq is set to begin Sept. 20.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars